Five-Year Residual Atherosclerotic Cardiovascular Disease Risk Prediction Model for Statin Treated Patients With Known Cardiovascular Disease-Reference-Cited by-同舟云学术

Five-Year Residual Atherosclerotic Cardiovascular Disease Risk Prediction Model for Statin Treated Patients With Known Cardiovascular Disease

Published:2020-12 Issue: Volume:137 Page:7-11
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Wong Nathan D.^ORCID,Zhao Yanglu,Xiang Pin,Coll Blai,López J. Antonio G.

Funder

National Heart, Lung, and Blood Institute

Abbott Laboratories

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

3. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels;N Engl J Med,1998

4. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators;Sacks;N Engl J Med,1996

5. Residual macrovascular risk in 2013: what have we learned?;Fruchart;Cardiovasc Diabetol,2014

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease;Mayo Clinic Proceedings;2024-08

2. Time-Dependent Risk for Recurrence in Survivors of Major Adverse Cardiovascular Events;Cureus;2024-04-30

3. An efficient cardio vascular disease prediction using multi-scale weighted feature fusion-based convolutional neural network with residual gated recurrent unit;Computer Methods in Biomechanics and Biomedical Engineering;2024-04-17

4. Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort;Journal of the American College of Cardiology;2024-04

5. Residual cardiovascular risk, use of standard care treatments, and achievement of treatment goals in patients with cardiovascular disease;International Journal of Cardiology Cardiovascular Risk and Prevention;2023-09